Concord Historical Income Statement
| CCM Stock | USD 0.63 0.01 1.56% |
Historical analysis of Concord Medical income statement accounts such as Selling General Administrative of 375.7 M, Total Revenue of 431.6 M or Cost Of Revenue of 754.1 M can show how well Concord Medical Services performed in making a profits. Evaluating Concord Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Concord Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Concord Medical Services latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Concord Medical Services is a good buy for the upcoming year.
Concord |
About Concord Income Statement Analysis
Concord Medical Services Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Concord Medical shareholders. The income statement also shows Concord investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Concord Medical Income Statement Chart
Concord Medical Services Income Statement is one of the three primary financial statements used for reporting Concord's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Concord Medical Services revenue and expense. Concord Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Concord Medical's Interest Expense is very stable compared to the past year. As of the 18th of April 2024, Selling General Administrative is likely to grow to about 375.7 M, though Gross Profit is likely to grow to (130.3 M). Add Fundamental
Total Revenue
Total revenue comprises all receipts Concord Medical Services generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Cost Of Revenue
Cost of Revenue is found on Concord Medical Services income statement and represents the costs associated with goods and services Concord Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Concord Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Concord Medical's Interest Expense is very stable compared to the past year. As of the 18th of April 2024, Selling General Administrative is likely to grow to about 375.7 M, though Gross Profit is likely to grow to (130.3 M).
Concord Medical income statement Correlations
Click cells to compare fundamentals
Concord Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Concord Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 46.2M | 28.7M | 81.4M | 120.4M | 138.4M | 145.3M | |
| Selling General Administrative | 291.9M | 315.1M | 294.8M | 311.2M | 357.8M | 375.7M | |
| Total Revenue | 190.9M | 198.4M | 223.0M | 472.1M | 542.9M | 431.6M | |
| Gross Profit | 19.8M | (15.8M) | 13.1M | (152.4M) | (137.2M) | (130.3M) | |
| Cost Of Revenue | 171.1M | 214.2M | 209.9M | 624.5M | 718.2M | 754.1M | |
| Income Tax Expense | 34.1M | (39.0M) | (37.6M) | (70.9M) | (63.8M) | (60.6M) | |
| Depreciation And Amortization | 54.6M | 173.7M | 101.1M | (56.1M) | (50.5M) | (48.0M) | |
| Selling And Marketing Expenses | 21.7M | 30.2M | 25.8M | 61.5M | 70.7M | 52.5M | |
| Other Operating Expenses | 484.7M | 559.6M | 530.5M | 997.1M | 1.1B | 1.2B | |
| Operating Income | (299.2M) | (437.3M) | (307.5M) | (525.0M) | (472.5M) | (448.9M) | |
| Ebit | (266.2M) | (437.3M) | (307.5M) | (525.0M) | (472.5M) | (448.9M) | |
| Ebitda | (211.6M) | (263.6M) | (206.4M) | (581.2M) | (523.1M) | (496.9M) | |
| Total Operating Expenses | 313.6M | 345.4M | 320.6M | 372.6M | 428.5M | 239.2M | |
| Income Before Tax | (225.2M) | (391.1M) | (441.7M) | (839.9M) | (755.9M) | (718.1M) | |
| Total Other Income Expense Net | 100.6M | 46.2M | (134.2M) | (314.8M) | (283.4M) | (269.2M) | |
| Net Income Applicable To Common Shares | (307.0M) | (669.9M) | (820.6M) | (489.7M) | (440.7M) | (418.7M) | |
| Net Income | (234.9M) | (352.1M) | (404.0M) | (769.0M) | (692.1M) | (657.5M) | |
| Minority Interest | 2.0B | 3.1B | 251.2M | 279.3M | 321.2M | 305.2M | |
| Net Income From Continuing Ops | (352.1M) | (404.0M) | (522.7M) | (769.0M) | (692.1M) | (657.5M) | |
| Tax Provision | (39.0M) | (37.6M) | (6.6M) | (70.9M) | (63.8M) | (60.6M) | |
| Interest Income | 10.4M | 8.4M | 5.9M | 10.0M | 9.0M | 8.6M | |
| Net Interest Income | (19.5M) | (72.9M) | (67.9M) | (110.3M) | (99.3M) | (104.3M) | |
| Reconciled Depreciation | 56.4M | 80.3M | 104.1M | 132.8M | 152.7M | 95.9M |
Pair Trading with Concord Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Concord Stock
| 0.63 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Concord Stock
| 0.87 | ELMD | Electromed | PairCorr |
| 0.83 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
| 0.8 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.79 | BAX | Baxter International Sell-off Trend | PairCorr |
| 0.73 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.
The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 14.017 | Quarterly Revenue Growth 0.972 | Return On Assets (0.05) | Return On Equity (0.31) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.